Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts

INTRODUCTION: Buruli ulcer (BU) is an infectious skin disease, caused by Mycobacterium ulcerans, endemic in more than 30 countries worldwide especially Africa. Brong-Ahafo Region implemented WHO recommended daily treatment with streptomycin and rifampicin for eight weeks (SR8). Yet limited assessmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Iddrisah, Florence Nzilanye, Yeboah-Manu, Dorothy, Nortey, Pricillia Awoh, Nyarko, Kofi Mensah, Anim, Jones, Antara, Simon Nyovuura, Kenu, Ernest, Wurapa, Fred, Afari, Edwin Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257010/
https://www.ncbi.nlm.nih.gov/pubmed/28149438
http://dx.doi.org/10.11604/pamj.supp.2016.25.1.6203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257010/
https://www.ncbi.nlm.nih.gov/pubmed/28149438
http://dx.doi.org/10.11604/pamj.supp.2016.25.1.6203

Ejemplares similares